Ma Jiayuan, Liu Peiling, Cai Shengliang, Wu Tao, Chen Dongying, Zhu Chaoyi, Li Shuang
School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.
J Agric Food Chem. 2024 Jan 10;72(1):493-503. doi: 10.1021/acs.jafc.3c05860. Epub 2023 Dec 18.
The strategy of active aggregation tag fusion expression with target proteins can solve the problems of restricted expression, inefficient purification, and laborious immobilization faced in the production of recombinant proteins in . We localized a novel active aggregation peptide HlyA60 from the hemolysin A secretion system, which can effectively induce aggregate formation with satisfactory protein activities in after fusion expression with the protein of interest. Based on structural prediction and surface properties, the process of active aggregation of HlyA60 through electrostatic interactions and hydrophobic interactions was analyzed. To investigate the potential application of HlyA60 as an efficient aggregation tag, it was fused with acetyl xylan esterase and lipase A, separately. The resulting fusion proteins demonstrated active aggregation rates of 97.6 and 66.7%, respectively, leading to 1.9-fold and 1.7-fold increases in bacterial density at the end of fermentation. The AXE-HlyA60 fusion protein, which exhibited superior performance, was subjected to purification and immobilization. It was able to achieve column-free purification with an impressive 98.8% recovery and in situ immobilization; the immobilization enabled 30 cycles of reactions to take place with 85% residual activity maintained. Our findings provide a novel tool for efficiently producing recombinant proteins in .
将活性聚集标签与目标蛋白融合表达的策略可以解决在大肠杆菌中生产重组蛋白时面临的表达受限、纯化效率低和固定化费力等问题。我们从溶血素A分泌系统中定位了一种新型的活性聚集肽HlyA60,在与目的蛋白融合表达后,它能在大肠杆菌中有效诱导聚集体形成,并具有令人满意的蛋白活性。基于结构预测和表面性质,分析了HlyA60通过静电相互作用和疏水相互作用进行活性聚集的过程。为了研究HlyA60作为一种高效聚集标签的潜在应用,分别将其与乙酰木聚糖酯酶和脂肪酶A融合。所得融合蛋白的活性聚集率分别为97.6%和66.7%,在发酵结束时使细菌密度分别提高了1.9倍和1.7倍。表现出优异性能的AXE-HlyA60融合蛋白进行了纯化和固定化。它能够实现无柱纯化,回收率高达98.8%,并能原位固定化;固定化后可进行30个循环反应,保持85%的残余活性。我们的研究结果为在大肠杆菌中高效生产重组蛋白提供了一种新工具。